Preclinical/subclinical rheumatoid arthritis-associated interstitial lung disease: misleading terms with potentially deleterious consequences

By sjmartinez • September 13, 2023

Volkmann ER, Sparks JA, Hoffmann-Vold AM, Doyle TJ, Emery P, Dieudé P. Preclinical/subclinical rheumatoid arthritis-associated interstitial lung disease: misleading terms with potentially deleterious consequences. Lancet Rheumatol. 2023 Mar;5(3):e116-e118. doi: 10.1016/s2665-9913(23)00033-4. Epub 2023 Feb 6. PMID: 37701927; PMCID: PMC10495035.

Tags: Publications, Rheumatology

Host targets of candidalysin

Lin J, Filler SG. Host targets of candidalysin. PLoS Pathog. 2025 Jun 23;21(6):e1013284. doi: 10.1371/journal.ppat.1013284. PMID: 40549807; PMCID: PMC12184922.

Chimneys

Reuben DB. Chimneys. JAMA Intern Med. 2025 Jun 23. doi: 10.1001/jamainternmed.2025.1822. Epub ahead of print. PMID: 40549397.

Efficacy and immune-related adverse events of pembrolizumab with bone-modifying agents in female patients with breast cancer

LeVee A, Peluso E, Lechner MG, Ruel N, Mortimer J, Kang I, Tsai K. Efficacy and immune-related adverse events of pembrolizumab with bone-modifying agents in[...]